Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
RYTM Transcript
Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-8
Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-13
Rhythm Pharmaceuticals, Inc. (RYTM) Q1 2026 Earnings Call Transcript
Unknown5-5
The earnings call summary shows a 25% revenue increase, which is positive, but the company still reported a net loss of $12.7 million. R&D expenses decreased, which may indicate cost-cutting, while SG&A expenses increased, suggesting investment in growth. Cash reserves decreased, potentially raising liquidity concerns. The absence of strategic initiatives, operational updates, and return discussions, coupled with unclear Q&A responses, leads to a neutral sentiment. Given the market cap, stock price movement is likely to be neutral in the next two weeks.
Kolibri Global Energy Inc. (KEI:CA) Q4 2025 Earnings Call Transcript
Positive3-20
The earnings call reveals strong financial performance with significant year-over-year growth in revenue, net income, and EBITDA, driven by higher production and cost efficiencies. Although forward-looking statements carry risks, the positive financial results are likely to outweigh uncertainties in the short term. The lack of strategic updates and shareholder return discussions is a minor concern, but the financial metrics suggest a positive stock price movement over the next two weeks.
RYTM Slides
Rhythm Pharmaceuticals Q1 2026 slides: revenue beats on HO launch2026-05-05
Rhythm Pharma Q4 2025 slides: revenue beats as HO launch nears2026-02-26
Rhythm Pharmaceuticals Q2 2025 slides: Revenue jumps 29%, obesity drugs show promise2025-08-05
Rhythm Pharmaceuticals Q1 2025 slides: Revenue grows 45% as HO program advances2025-05-07
RYTM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.